VXRT Relative Valuation - Vaxart Inc - Alpha Spread

Vaxart Inc
NASDAQ:VXRT

Watchlist Manager
Vaxart Inc Logo
Vaxart Inc
NASDAQ:VXRT
Watchlist
Price: 0.8344 USD -7.91% Market Closed
Market Cap: 189.8m USD
Have any thoughts about
Vaxart Inc?
Write Note

Relative Value

The Relative Value of one VXRT stock under the Base Case scenario is 0.8859 USD. Compared to the current market price of 0.8344 USD, Vaxart Inc is Undervalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VXRT Relative Value
Base Case
0.8859 USD
Undervaluation 6%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
39
Median 3Y
689.4
Median 5Y
110.1
Industry
7.8
Forward
15.3
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-3.3
Industry
23.7
Forward
-1.7
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-4.6
Industry
22.3
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-3.4
Industry
24.8
vs History
57
vs Industry
42
Median 3Y
2.5
Median 5Y
3.2
Industry
2.5
vs History
79
vs Industry
39
Median 3Y
146.6
Median 5Y
82.7
Industry
7.6
Forward
10.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.8
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-3.2
Industry
4.8
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-3.1
Industry
4.5
Forward
-1.3
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-3.5
Industry
6.4
vs History
vs Industry
Median 3Y
-1.9
Median 5Y
-3.2
Industry
4.4
vs History
53
vs Industry
49
Median 3Y
2.9
Median 5Y
4.1
Industry
4.8

Multiples Across Competitors

VXRT Competitors Multiples
Vaxart Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Vaxart Inc
NASDAQ:VXRT
189.8m USD 13.6 -2.5 -1.9 -1.7
US
Abbvie Inc
NYSE:ABBV
341.7B USD 6.2 64.5 15.8 24.1
US
Amgen Inc
NASDAQ:AMGN
181.2B USD 5.9 57.9 20.2 36.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
127.2B USD 9.4 29.4 25.8 28.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120B USD 11.6 -244.9 26 27.3
US
Epizyme Inc
F:EPE
94.1B EUR 1 981.8 -505.7 -550.7 -536
US
Gilead Sciences Inc
NASDAQ:GILD
104.6B USD 3.8 99.3 9.4 12
AU
CSL Ltd
ASX:CSL
141.9B AUD 6.5 36.6 22.4 27.9
US
Seagen Inc
F:SGT
39.3B EUR 19.1 -58.5 -63 -56.9
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD 6 513.5 -1 169.6 -1 185.3 -1 173.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.1B USD 15 -481 211.7 325.9
P/E Multiple
Earnings Growth
US
Vaxart Inc
NASDAQ:VXRT
Average P/E: 57.5
Negative Multiple: -2.5
N/A
US
Abbvie Inc
NYSE:ABBV
64.5
406%
US
Amgen Inc
NASDAQ:AMGN
57.9
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.4
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -244.9
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
99.3
71%
AU
CSL Ltd
ASX:CSL
36.6
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -481 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Vaxart Inc
NASDAQ:VXRT
Average EV/EBITDA: 47.3
Negative Multiple: -1.9
N/A
US
Abbvie Inc
NYSE:ABBV
15.8
28%
US
Amgen Inc
NASDAQ:AMGN
20.2
57%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.8
47%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26
39%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -550.7 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
9.4
10%
AU
CSL Ltd
ASX:CSL
22.4
45%
US
S
Seagen Inc
F:SGT
Negative Multiple: -63 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 185.3 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
211.7
N/A
EV/EBIT Multiple
EBIT Growth
US
Vaxart Inc
NASDAQ:VXRT
Average EV/EBIT: 68.9
Negative Multiple: -1.7
N/A
US
Abbvie Inc
NYSE:ABBV
24.1
86%
US
Amgen Inc
NASDAQ:AMGN
36.7
95%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
28.6
49%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.3
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -536 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
12
26%
AU
CSL Ltd
ASX:CSL
27.9
59%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.9 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 173.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
325.9
N/A

See Also

Discover More
Back to Top